Krebs Biochemicals and Industries Limited — Others, 21-05-2025: Copy of Newspaper Publication

Krebs Biochemicals & Industries Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income from operations of Rs. 50.87 Cr and a net loss of Rs. 19.73 Cr after tax for the year, with earnings per share at a negative Rs. 9.15. Ongoing losses indicate operational challenges, suggesting that near-term profitability remains under pressure for shareholders to monitor closely.